Front Range Biosciences acquires Steep Hill R&D team

LAFAYETTE — Front Range Biosciences Inc., an agricultural biotech company focused on high-value crops such as cannabis, has acquired the research and development team of Steep Hill Inc., a California-based cannabis genetics testing and analysis firm.

“The Steep Hill R&D team is among the top three cannabis genomics groups in the world, and we are very excited to welcome them to FRB,” CEO Jonathan Vaught said in a prepared statement. “This acquisition is a major value inflection point for FRB, as the intellectual property we acquired significantly expands the value of our current portfolio and provides a…